Finerenone Also Slows Kidney Decline in Diabetes-Free Patients

Finerenone (Kerendia) slowed kidney function decline in adults with chronic kidney disease (CKD) who do not have diabetes, according to the FIND-CKD trial. The trial demonstrated a reduced annual rate of change in estimated kidney function by month 32.